Stay updated on Clinical Trial: Nozin for Respiratory Viral Infections
Sign up to get notified when there's something new on the Clinical Trial: Nozin for Respiratory Viral Infections page.

Latest updates to the Clinical Trial: Nozin for Respiratory Viral Infections page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the PREV-NOSE study, including its terminated status, study design, eligibility criteria, locations, and outcome measures.SummaryDifference44%

- Check20 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check27 days agoChange DetectedA notice was added announcing NIH website changes and explaining that some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check41 days agoChange DetectedThe ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check62 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the study content with a generic error view. This blocks access to the trial details on this page.SummaryDifference17%

Stay in the know with updates to Clinical Trial: Nozin for Respiratory Viral Infections
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Nozin for Respiratory Viral Infections page.